Sign Up Today and Learn More About Genespire Stock
Invest in or calculate the value of your shares in Genespire or other pre-IPO companies through EquityZen's platform.
Genespire Stock
Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.
About Genespire Stock
Founded
2020
Industries
Software, Artificial Intelligence, Data and Analytics
Genespire Press Mentions
Stay in the know about the latest news on Genespire
Fierce Biotech Fundraising Tracker ’24: Genespire gathers $52M series B; Vicebio secures $100M
sdbn • Oct 23, 2024
Genespire raises €47M to advance Gene-202, lentiviral vectors
bioworld • Sep 27, 2024
Genespire Raises €46.6M in Series B Funding
finsmes • Sep 26, 2024
Genespire claims one of Italian biotech’s biggest fundraisers yet
thepharmaletter • Sep 26, 2024
Genespire appoints Karen Aiach-Pignet as Chief Executive Officer
globenewswire • Sep 12, 2024
Genespire Management
Leadership team at Genespire
CEO
Karen Pignet-Aiach
Board Member
Graziano Seghezzi
Join now and verify your accreditation status to gain access to:
- Genespire current valuation
- Genespire stock price
- Available deals in Genespire and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Genespire stock?
Accredited investors can buy pre-IPO stock in companies like Genespire through EquityZen funds. These investments are made available by existing Genespire shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Genespire stock?
Shareholders can sell their Genespire stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
